Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | ACACB | O00763 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5560846 | 0.82 | PPARA (0.38) | PPARAALDH1A1LMNAACACB | |
| SCHEMBL127434 | 0.81 | CYP3A4 (0.47) | PPARAALDH1A1LMNAACACB | |
| SCHEMBL7650076 | 0.80 | LTA4H (0.46) | PPARAALDH1A1LMNAACACB | |
| SCHEMBL2468529 | 0.77 | MAPT (0.45) | PPARAALDH1A1 | |
| SCHEMBL196997 | 0.76 | THRB (0.57) | PPARAALDH1A1LMNAACACB | |
| SCHEMBL6562700 | 0.76 | POLB (0.50) | PPARAALDH1A1LMNAACACB | |
| SCHEMBL3680771 | 0.76 | PPARD (0.40) | PPARAALDH1A1LMNAACACB | |
| SCHEMBL3677849 | 0.76 | LMNA (0.40) | PPARAALDH1A1LMNAACACB | |
| SCHEMBL6276346 | 0.76 | LMNA (0.51) | ALDH1A1LMNA | |
| SCHEMBL7764968 | 0.75 | CYP3A4 (0.45) | PPARAALDH1A1LMNAACACB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107849165-B | Photopolymerization initiator composition, active energy ray-curable composition, and cured product | 富士胶片株式会社 | 2020-03-17 | — | — | CN | disclosed |
| EP-3330295-B1 | PHOTOPOLYMERIZATION INITIATOR COMPOSITION, ACTIVE ENERGY RAY-CURABLE COMPOSITION, AND CURED PRODUCT | FUJIFILM CORP (JP) | 2019-08-21 | — | — | EP | disclosed |
| EP-3330295-A1 | PHOTOPOLYMERIZATION INITIATOR COMPOSITION, ACTIVE ENERGY RAY-CURABLE COMPOSITION, AND CURED PRODUCT | FUJIFILM Corporation (JP) | 2018-06-06 | — | — | EP | disclosed |
| US-20180148519-A1 | PHOTOPOLYMERIZATION INITIATOR COMPOSITION, ACTIVE ENERGY RAY-CURABLE COMPOSITION, AND CURED PRODUCT | FUJIFILM CORPORATION (JP) | 2018-05-31 | — | — | US | disclosed |
| EP-1451615-B1 | METHOD FOR MODIFYING THE SURFACE OF BIOMEDICAL ARTICLES | NOVARTIS AG (CH) | 2007-11-14 | — | — | EP | disclosed |
| US-6878399-B2 | Method for modifying the surface of biomedical articles | NOVARTIS AG (CH) | 2005-04-12 | — | — | US | disclosed |
| EP-1451615-A1 | METHOD FOR MODIFYING THE SURFACE OF BIOMEDICAL ARTICLES | Novartis AG (CH) | 2004-09-01 | — | — | EP | disclosed |
| US-20030219533-A1 | Method for modifying the surface of biomedical articles | NOVARTIS AG (CH) | 2003-11-27 | — | — | US | disclosed |
| WO-2003042724-A1 | METHOD FOR MODIFYING THE SURFACE OF BIOMEDICAL ARTICLES | NOVARTIS AG (CH) | 2003-05-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180148519-A1 | PHOTOPOLYMERIZATION INITIATOR COMPOSITION, ACTIVE ENERGY RAY-CURABLE COMPOSITION, AND CURED PRODUCT | PARP1, PARP9, PARP4 | PPARA 3522/4885ALDH1A1 1761/4885LMNA 389/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.